Dani Bancroft, Author at Labiotech.eu - Page 11 of 23

About

Former Editor, now flitting back and forth as a freelancer. Originally from London and studied Zoology at the University of Reading, UK. Previous work includes having written for The Spark University Newspaper and the Wellcome Trust.

Articles by Dani Bancroft

embl microbiome janssen eligo enterome jj inra therapeutics crohns

News and Trends 7 Jan 2016

Collaboration is Key to Microbiomics: New Deal with The Janssen Human Microbiome Institute

The Janssen Human Microbiome Institute, the French National Institute for Agricultural Research (INRA) and Johnson & Johnson Innovation AND Takeda are signing up to collaborate with the Paris biotech Enterome to help accelerate Microbiomics research into Crohn’s Disease. The collaboration is based on initial findings by the INRA showing that some commensal (symbiotic) bacteria elicit […]

January 7, 2016 - 3 minutesmins - By Dani Bancroft

merck msd cancer immunoncology complix alphabody

News and Trends 7 Jan 2016

Alphabody Platform for Cancer Draws in €260M Discovery Deal with MSD

Complix is a Belgian Immuno-Oncology Biotech with a proprietary Alphabody platform, which has now attracted a €260M strategic drug discovery collaboration with Merck Sharp & Dohme (MSD). Under the terms of the agreement, Complix will use its proprietary Alphabody platform to tackle two intra-cellular cancer targets. One example is the myeloid leukemia cell-1 protein (MCL-1), […]

January 7, 2016 - 2 minutesmins - By Dani Bancroft

audi global bioenergies biofuels car isobutene

News and Trends 6 Jan 2016

Audi Strengthens Collaboration with French Biotech for the Future of Automotive Biofuels

Audi is entering a renewed collaboration agreement with French Global Bioenergies to further broaden the flexibility of their biofuels technology for Greener Cars. The Paris based Global Bioenergies approach to second-generation isobutene production (using non-edible sources of biomass – e.g. wood chips) has turned out to be hugely popular, earning a €1.4M investment back in […]

January 6, 2016 - 2 minutesmins - By Dani Bancroft

porridge vomit emesis acacia trial baremsis

News and Trends 5 Jan 2016

Say Goodbye to Post-Operation Nausea with this Phase III UK Trial Success

An anti-vomiting medication for post-operative patients has smashed its phase III trial in the UK in one of the largest ever post-operation-nausea studies…ever. Roll on FDA approval. Acacia Pharma is a Cambridge based clinical-stage biotech which looks to provide supportive care of patients with debilitating conditions arising as a consequence of surgery, cancer or cancer treatment. […]

January 5, 2016 - 3 minutesmins - By Dani Bancroft

msd avelumab pdl1 immunooncology pfizer etinostat

News and Trends 5 Jan 2016

How these Latest Trials Prove PD-L1 as The Breakthrough Trend in Immuno-Oncology that is Here to Stay…

By targeting platinum resistant Ovarian cancer, Avelumab is a new anti-PD-L1 checkpoint inhibitor on the Cancer block. This just affirms how PD-L1 receptor is seen as the current breakthrough therapeutic target in Immuno-Oncology. Program-Death ligand 1 (PD-L1) is already a common target for mAbs in immuno-oncology. If expressed on the tumor cells, this enables the […]

January 5, 2016 - 3 minutesmins - By Dani Bancroft

nanomedicine nanoxray nanobiotix prostatecancer trials

News and Trends 4 Jan 2016

French Nano-Xrays to Kill Prostate Cancer in Phase I/II Trial

A Parisian Nanomedicine biotech is using it’s proprietary NanoXray technology to enhance radiotherapy. Now a candidate to treat Prostate cancer has received FDA approval for a phase I/II trial in the US. Nanobiotix is seeking to develop NBTXR3 for patients with intermediate and high-risk prostate cancer, with the aim of providing effective tumor destruction and […]

January 4, 2016 - 3 minutesmins - By Dani Bancroft

ADVERTISEMENT

leukemia ucart19 cellectis cancer cart trial UK

News and Trends 4 Jan 2016

Cellectis Full-Steam Ahead with UCART19 Trial for Leukemia in the UK

So it begins…dubbed the ‘Miracle Cure’ for Blood Cancer, UCART19 is now set to begin its journey to Human trials in the UK. Just 2 days before Christmas, the French billion euro Biotech, Cellectis, submitted a clinical trial application to the Medicines & Healthcare products Regulatory Agency (MHRA). Specifically, the request was to approve initiation […]

January 4, 2016 - 2 minutesmins - By Dani Bancroft

aging regenerative medicine genetics genome longevity

News and Trends 4 Jan 2016

Genomics’ Holy Grail: The Secret to Super-Longevity Lies in your Genes

The search for the Holy Grail in aging has long been a focus in regenerative medicine, which poses the question: why do some of us age better than others? Now growing evidence in Genomic Studies shows that there are key genetic players in the Aging game… Ever since the Human Genome Project, which began 25 […]

January 4, 2016 - 4 minutesmins - By Dani Bancroft

jeremiah draws greentech biotech living city

News and Trends 30 Dec 2015

Who Tried to Save the World in 2015? The Coolest Developments in GreenTech this year…

Biofuels, bioplastics, Moss-based drugs and algae for food. All of these are pioneering areas of GreenTech progress this year. So what are the major developments in this forward-thinking field? 1. 100% Biodegradable Potato Plastics The Italian company Bio-On from Bologna is specialized in the production of environmentally sustainable materials, including Minverv PHAs. These are ‘green’ […]

December 30, 2015 - 5 minutesmins - By Dani Bancroft

biotech films movies science fiction

News and Trends 23 Dec 2015

7 Biotech-y Blockbusters to Chill Out With…

Tired of seeing a mini Macaulay Culkin in Home Alone – again – this Christmas? Don’t panic, here is a Biotech related film selection me and Nuria (our Events Manager) came up with for the sake for your survival’s sake this holiday… 1. Gattaca (1997) Directed by Andrew Nicole, with Ethan Hawke, Uma Thurman, Jude Law […]

December 23, 2015 - 6 minutesmins - By Dani Bancroft

crispr bayer therapeutics genetic disease joint venture london

News and Trends 22 Dec 2015

Serious Genetic Diseases have a New CRISPR Dream Duo Venture worth in Excess of €275M

Blood disorders, blindness and congenital heart disease? The new Bayer Life Science Center (BLSC) in Germany and CRISPR Therapeutics (Switzerland) have now created a joint Venture to tackle cures for these rare genetic defects. CRISPR Therapeutics will contribute its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise […]

December 22, 2015 - 2 minutesmins - By Dani Bancroft

mimetas organ on chip

News and Trends 22 Dec 2015

Dutch Organ-on-Chip Biotech Hauls in €1.5M Funding from Pharma Syndicate in Project Against Animal Testing

Mimetas from Leiden (NL) has now been financed to develop an Organ-on-Chip (tissue model) to specifically test Neurotoxicity, as a piece of medtech to help clinical trials move away from Animal testing… Organs-on-Chips are microfluidic tissue models which mimic basic organ-to-organ coupling. Developed with the aim of simulating ADMET testing and drug screening in vitro, […]

December 22, 2015 - 3 minutesmins - By Dani Bancroft

ADVERTISEMENT